The expression of the adenosine pathway markers CD39 and CD73 in salivary gland carcinomas harbors the potential for novel immune checkpoint inhibition

被引：0

作者：

Arthur Bauer

Niklas Gebauer

Juliana Knief

Lars Tharun

Nele Arnold

Armin Riecke

Konrad Steinestel

Hanno M. Witte

机构：

[1] Federal Armed Forces Hospital Ulm,Department of Hematology and Oncology

[2] Federal Armed Forces Hospital Ulm,Institute of Pathology and Molecular Pathology

[3] University Hospital of Schleswig-Holstein,Department of Hematology and Oncology

[4] Marienkrankenhaus Hamburg,Institute of Pathology

[5] University Hospital of Schleswig-Holstein,Institute of Pathology

[6] Federal Armed Forces Hospital Hamburg,Department of ENT

来源：

Journal of Cancer Research and Clinical Oncology | 2023年 / 149卷

关键词：

SGC; CD39; CD73; Adenosine signaling; Immunotherapy;

D O I：

暂无

中图分类号：

学科分类号：

摘要：

引用

页码：3193 / 3208

页数：15

共 50 条

[21] Low expression of CD39 and CD73 genes in centenarians compared with octogenarians
Almudena Crooke
Juan Martínez-Henández
Joaquín Martínez-López
Alfonso Cruz-Jentoft
Fernando Huete-Toral
Jesús Pintor
Immunity & Ageing, 14
[22] A Novel Antagonistic CD73 Antibody for Inhibition of the Immunosuppressive Adenosine Pathway
Wurm, Melanie
Schaaf, Otmar
Reutner, Katharina
Ganesan, Rajkumar
Mostboeck, Sven
Pelster, Christina
Boettcher, Jark
Pereira, Bruna de Andrade
Taubert, Christina
Alt, Isabella
Serna, Garazi
Auguste, Aurelie
Stadermann, Kai B.
Delic, Denis
Han, Fei
Capdevila, Jaume
Nuciforo, Paolo G.
Kroe-Barrett, Rachel
Adam, Paul J.
Vogt, Anne B.
Hofmann, Irmgard
MOLECULAR CANCER THERAPEUTICS, 2021, 20 (11) : 2250 - 2261
[23] Relationship between the Gene Expression of Adenosine Kinase Isoforms and the Expression of CD39 and CD73 Ectonucleotidases in Colorectal Cancer
Zhulai, G. A.
Shibaev, M. I.
ACTA NATURAE, 2023, 15 (02): : 42 - 49
[24] Expression of adenosine generating ecto-enzymes, CD39 and CD73, in lymphocytes in tumor bearing mouse
Tsukui, Hidenori
Ohzawa, Hideyuki
Yamaguchi, Hironori
Sakuma, Yasunaru
Hosoya, Yoshinori
Horie, Hisanaga
Fujii, Hirofumi
Sata, Naohiro
Kitayama, Joji
CANCER SCIENCE, 2018, 109 : 383 - 383
[25] CD39/CD73 Pathway in End-stage Human Ischemic Cardiomyopathy
Novitskaya, Tatiana
Su, Yan Ru
Maltais, Simon
Absi, Tarek S.
Gumina, Richard J.
CIRCULATION, 2014, 130
[26] The CD39/CD73/Adenosine and NAD/CD38/CD203a/CD73 Axis in Cutaneous T-Cell Lymphomas
Lin, Liyun
Roccuzzo, Gabriele
Yakymiv, Yuliya
Marchisio, Sara
Ortolan, Erika
Funaro, Ada
Senetta, Rebecca
Pala, Valentina
Bagot, Martine
de Masson, Adele
Battistella, Maxime
Guenova, Emmanuella
Ribero, Simone
Quaglino, Pietro
CELLS, 2025, 14 (04)
[27] Targeting Metabolism of Extracellular Nucleotides via Inhibition of Ectonucleotidases CD73 and CD39
Jeffrey, Jenna L.
Lawson, Kenneth, V
Powers, Jay P.
JOURNAL OF MEDICINAL CHEMISTRY, 2020, 63 (22) : 13444 - 13465
[28] Role of the CD39/CD73 Purinergic Pathway in Modulating Arterial Thrombosis in Mice
Covarrubias, Roman
Chepurko, Elena
Reynolds, Adam
Huttinger, Zachary M.
Huttinger, Ryan
Stanfill, Katherine
Wheeler, Debra G.
Novitskaya, Tatiana
Robson, Simon C.
Dwyer, Karen M.
Cowan, Peter J.
Gumina, Richard J.
ARTERIOSCLEROSIS THROMBOSIS AND VASCULAR BIOLOGY, 2016, 36 (09) : 1809 - 1820
[29] Skewed CD39/CD73/adenosine pathway in B cells is associated with innate immune hyperactivation in chronic HIV-1 infection
Wen-Xian Chang
Hui-Huang Huang
Lei Huang
Ji-Jing Shi
Yan-Mei Jiao
Chao Zhang
Lei Jin
Tao Yang
Ming Shi
Bo Tu
Zhe Xu
Tian-Jun Jiang
Fu-Sheng Wang
Ji-Yuan Zhang
Translational Medicine Communications, 4 (1)
[30] Dysregulation in CD39/CD73 Axis May Trigger the Upsurge of the Immune Suppressive Agent Adenosine in OSA Patients
Diaz-Garcia, Elena
Garcia-Sanchez, Aldara
Alfaro, Enrique
Lopez-Fernandez, Cristina
Manas, Eva
Casitas, Raquel
Vega, Sara
Cano-Pumarega, Irene
Garcia-Rio, Francisco
Cubillos-Zapata, Carolina
ARCHIVOS DE BRONCONEUMOLOGIA, 2024, 60 (04): : 207 - 214

← 1 2 3 4 5 →